Skip to main content

Meet the Analyst: Thomas Wakim & John Hester, Bell Potter Analyst

Bell Direct
December 17, 2024

Join us as we conclude our 2024 Meet the Analyst series with a bang. Our Market Analyst, Grady Wulff, sits down with Bell Potter’s analysts John Hester and Thomas Wakim for a comprehensive discussion on the healthcare sector.

From deciphering Neuren Pharmaceuticals (ASX:NEU) share price fluctuations to anticipating the news flow that will share 2025 guidance and identifying why Telix Pharmaceuticals (ASX:TLX) and Clarity Pharmaceuticals (ASX:CU6) are stocks to watch in the new year, John and Thomas cover it all in this final episode of the year.

In this video, John and Thomas discuss:

  • (1:48): the headwinds & tailwinds facing the healthcare sector
  • (7:10): why they are bullish on Neuren
  • (13:48): opportunities in healthcare stocks for 2025
  • (15:18): what’s on their clinical data radar for the upcoming year.

Weekly Wrap 30 September

Grady Wulff
September 30, 2022

Morning Bell 30 September

Sophia Mavridis
September 30, 2022

Closing Bell 29 September

Grady Wulff
September 29, 2022

Morning Bell 29 September

Grady Wulff
September 29, 2022

Morning Bell 28 September

Grady Wulff
September 28, 2022

Closing Bell 27 September

Sophia Mavridis
September 27, 2022

Morning Bell 27 September

Sophia Mavridis
September 27, 2022

Closing Bell 26 September

Grady Wulff
September 26, 2022

Morning Bell 26 September

Grady Wulff
September 26, 2022

Morning Bell 23 September

Sophia Mavridis
September 23, 2022

Closing Bell 21 September

Grady Wulff
September 21, 2022

Morning Bell 21 September

Grady Wulff
September 21, 2022